Sign in
CompletedPhase 1

A study of the safety, tolerability, pharmacokinetics and preliminary efficacy of TNV108 in healthy adults and patients with diabetic peripheral neuropathy

Key facts

Who runs it
Tenvie Therapeutics Inc.
Where
Netherlands1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 1
People taking part
108 people enrolled
Started
2 Mar 2026
Ended
30 Oct 2026
Type of study
Interventional
Record updated
24 February 2026

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Can take part

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
24 February 2026